Tasigna (Nilotinib) is a targeted therapy used in the treatment of certain types of leukemia, especially Chronic Myeloid Leukemia (CML). It works by specifically targeting cancer cells to help control disease progression.
What is Tasigna (Nilotinib)?
Tasigna belongs to a class of drugs known as Tyrosine Kinase Inhibitors (TKIs). It targets the BCR-ABL protein responsible for abnormal cancer cell growth in CML.
In Chronic Myeloid Leukemia, this protein causes uncontrolled production of abnormal blood cells. Tasigna works by:
Blocking cancer cell growth signals
Reducing abnormal blood cell proliferation
Helping control disease progression
In simple terms: It targets the molecular cause behind leukemia cell growth.
Indications
Tasigna (Nilotinib) is used in:
Chronic Myeloid Leukemia (CML)
Philadelphia chromosome-positive (Ph+) leukemia cases
Dosage and Administration
Dose depends on the condition and treatment protocol
Taken orally
Usually twice daily
Should be taken consistently at the same times every day
Preferably taken away from food according to physician instructions
Common Side Effects
May include:
Headache
Nausea
Skin rash
Fatigue
Muscle pain
Liver function abnormalities
Rarely: heart-related side effects requiring close monitoring.
Monitoring During Treatment
Patients on Tasigna (Nilotinib) require:
Complete blood count monitoring
Liver function tests
ECG monitoring
Evaluation of treatment response
Availability & How to Access Treatment
Tasigna (Nilotinib) is available through Macrocare’s approved partners.
You can now request and access the medication easily through us.
WhatsApp contact for medication requests: Click here
Tasigna (Nilotinib)Tasigna (Nilotinib) 150 mg is an effective targeted therapy for CML that works by blocking abnormal leukemia cell growth and improving disease control.
Medical Disclaimer: This content is for educational purposes only and does not replace professional medical advice. Treatment decisions should always be made by a qualified physician.
